These DAT-PF-tTA mice conditionally express tetracycline responsive transactivator (tTA) in dopamine neurons from the mouse Slc6a3 (DAT) promoter. A “PF” (tetO-tTA) positive feedback cassette is incorporated in the construct to amplify tTA expression. Homozygotes have little or no endogenous SLC6A3/DAT expression and show growth retardation. These mice may be useful for studying gene function in dopaminergic neurons, such as drug addiction, Parkinson's disease and Attention Deficit-Hyperactivity Disorder (ADHD).
Xiaoxi Zhuang, The University of Chicago
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Transactivator) | Slc6a3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
These DAT-PF-tTA mice express tetracycline responsive transactivator (tTA) in dopamine neurons from the mouse Slc6a3 (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3; also called DAT) promoter. A downstream “PF” (tetO-tTA) positive feedback amplification cassette enhances tTA expression, but itself has no transcription activity due to an upstream "stop". Homozygotes have little or no endogenous SLC6A3/DAT expression and show growth retardation.
When these tTA mice are crossed with tetO-human α-synuclein A53T mutant animals (see Stock No. 012442), double mutant DASYN53 mice develop features of Parkinson’s disease. These animals do not have detectable transgenic α-synuclein protein expression at 1 week after birth, later than endogenous DAT expression (E15–E17), suggesting that the transgene amplification through “PF” may increase gradually. This pattern of expression can help avoid complications in phenotype interpretation due to early developmental effects. At 6 weeks, the DASYN53 mice have transgenic α-synuclein expression in more than 95% of dopamine neurons in the midbrain. The DASYN53 mice showed profound early-onset mitochondria abnormalities, characterized by macroautophagy marker-positive cytoplasmic inclusions containing mainly mitochondrial remnants, which precede the degeneration of dopamine neurons.
The following were inserted, in order, between the promoter and coding sequences of the mouse Slc6a3 (DAT) gene: tTA-pA-STOP-“PF” [TetO-tTA] cassette-pA-loxP-Neo-loxP. The mutation was created through homologous recombination in Primogenix PRX-129/S6 embryonic stem (ES) cells. Resultant chimeric males were crossed with Meox2-cre germline deleter mice (see Stock No. 003755) to excise the PGK-neomycyin cassette. This strain was maintained on a mixed C57BL/6 and 129S genetic background by the donating laboratory.
Allele Name | targeted mutation 4.1, Xiaoxi Zhuang |
---|---|
Allele Type | Targeted (Transactivator) |
Allele Synonym(s) | DAT-PF-tTA |
Gene Symbol and Name | Slc6a3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
Gene Synonym(s) | |
Site of Expression | Tetracycline responsive transactivator (tTA) is expressed in dopamine neurons. |
Strain of Origin | 129S6/SvEvTac |
Chromosome | 13 |
Molecular Note | The following were inserted, in order, between the promoter and coding sequences of the endogenous gene: tTA-pA-STOP-"PF" [TetO-tTA] cassette-pA-loxP-Neo-loxP. The PF (positive feedback) amplification cassette enhances tTA expression following the removal of the STOP. Cre-mediated recombination removed the downstream floxed neo cassette. Transgene expression is eight-fold higher than endogenous alpha-synuclein expression in dopaminergic neurons. |
Heterozygotes are viable and fertile. Homozygotes are growth-retarded.
When using the DAT-PF-tTA mouse strain in a publication, please cite the originating article(s) and include JAX stock #027178 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Slc6a3<tm4.1(tTA)Xz> |
Frozen Mouse Embryo | B6;129S-Slc6a3<tm4.1(tTA)Xz>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6;129S-Slc6a3<tm4.1(tTA)Xz>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6;129S-Slc6a3<tm4.1(tTA)Xz>/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6;129S-Slc6a3<tm4.1(tTA)Xz>/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.